Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05924191
Other study ID # CIRUCU
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date November 30, 2023
Est. completion date July 8, 2024

Study information

Verified date June 2023
Source University of Nove de Julho
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Third molar extraction is one of the most performed surgical procedures in Dentistry. A comfortable postoperative period and rapid return to daily activities increase the need to control the inflammatory response and its signs and symptoms such as pain, edema, and lockjaw. Therefore, the objective of this study is to evaluate the efficacy of the prophylactic use of Photobiomodulation in the reduction of edema in the postoperative period of extractions of retained lower third molars.The primary study variable will be postoperative edema measured in millimeters, 48 hours after surgery, and the secondary variables will be: pain, lockjaw, local temperature (measured with a thermographic camera), dysphagia, and the need to ingest nonsteroidal analgesics (Acetaminophen)These variables will be evaluated at the beginning of the study (baseline), at 2 and 7 days post-surgery. All adverse effects will be recorded. The data obtained will be represented by their means ± SD and the p value will be set at 0.05.


Description:

Third molar extraction is one of the most performed surgical procedures in Dentistry. A comfortable postoperative period and rapid return to daily activities increase the need to control the inflammatory response and its signs and symptoms such as pain, edema, and lockjaw. To control these events, the prophylactic use of anti-inflammatory steroids has been widely recommended by some authors. However, there is no strong evidence on the real benefits of its use as opposed to its possible side effects. Photobiomodulation has proven to be a good alternative when applied in the postoperative period to control pain, edema and lockjaw. On the contrary, its application prior to a procedure of this type has not been sufficiently evaluated. Therefore, the objective of this study is to evaluate the efficacy of the prophylactic use of Photobiomodulation in the reduction of edema in the postoperative period of extractions of retained lower third molars. Healthy individuals (ASA I), who have an indication for extraction and are included in the study, will be randomly divided into two groups: Control Group: with the administration of prophylactic Corticosteroid (Dexamethasone 8 mg/ 1h before surgery), and the simulated application of Photobiomodulation, under the same protocol as the Study Group and Study Group: to which Photobiomodulation will be applied by means of intraoral Low Intensity Laser with wavelengths of 660nm and 808nm applied at 4 anatomical points (power of 0.1W, radiant exposure of 1,061 J/cm2 and energy of 3J per point and an application time of 30 seconds, totaling 12J of energy). Besides, the extraoral application will be carried out with a cluster device of combined LEDs with a total exposure area of 20cm2, which will be composed of 5 LEDs with a wavelength of 630nm (power of 0.25W per LED, a radiant exposure of 3 J /cm2 and energy of 12 J per LED spot, with an exposure time of 48 seconds) and 4 LEDs with a wavelength of 850 nm (power of 0.3W per LED, a radiant exposure of 2.4 J/cm2 and an energy of 12J per LED point, and an exposure time of 40 seconds). The Study Group will be administered a placebo tablet simulating Dexamethasone, also 1 h before the surgical procedure. The primary study variable will be postoperative edema measured in millimeters, 48 hours after surgery, and the secondary variables will be: pain, lockjaw, local temperature (measured with a thermographic camera), dysphagia, and the need to ingest nonsteroidal analgesics (Acetaminophen) after the first 3 postoperative days, where Ketorolac 10 mg will be administered orally, in a regulated manner. These variables will be evaluated at the beginning of the study (baseline), at 2 and 7 days post-surgery. All adverse effects will be recorded. The data obtained will be represented by their means ± SD and the p value will be set at 0.05. Keywords: photobiomodulation, corticosteroids, extraction, edema, pain, lockjaw, quality of life, randomized controlled trial.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 30
Est. completion date July 8, 2024
Est. primary completion date May 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Patients who present retained lower third molars, according to the degree of surgical difficulty of the procedure and the anatomical position.The selected molars will be those classified according to classes II and III and/or B or C of Pell and Gregory Classification; in vertical or mesio-angular position, according to the Winter Classification or Class II with need for ostectomy or III, with need for ostectomy and odontosection of the Prant Scale, modified by Amarillas-Escobar et al. - That have an indication for the extraction of the lower third molars (due to recurrent infections, bad anatomical position, orthodontic indication) or a professional indication presented in writing and that are healthy (ASA I, with a negative medical history). - Male or female gender. - Age between 18 and 50 years. - Good oral hygiene. - That they agree to participate in the study, after reading and signing the Informed Consent for participation in clinical research. Exclusion Criteria: - Carriers of local alterations that contraindicate surgical intervention or complicate the postoperative period (example: acute phase pericoronitis in the last 30 days, ankylosis of the temporomandibular joint). - Smokers, - Presenting absence of upper and lower central incisors, - With a medical history of photosensitivity - During pregnancy or lactation, - That they were using anti-inflammatories or analgesics, - Allergic to any of the drugs used in the research (amoxicillin, ketorolac, acetaminophen, dexamethasone, chlorhexidine 2%, local anesthetics, sodium bisulfite, etc.) - That during surgery they present any type of complication (bleeding, transoperative difficulties, etc.), because these cases are not included within the expected pattern behavior for this type of surgery (these cases will be reported), - Surgical time greater than 90 minutes.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Photobiomodulation
Intra-oral irradiations wll be performed with a low intensity Laser device at 4 anatomical points, with a wavelength of 660 nm. The extraoral FBM will be applied with 1 cluster (20cm2) with a wavelength of 630nm. Subsequently, the same region will be irradiated with the same cluster, using the 4 LEDs with a wavelength of 850 nm 1 hour before performing the surgery.
Drug:
Placebo Corticosteroid
Participants will receive 1 hour before the surgery a placebo tablet, with the same physical and organoleptic characteristics, composed of corn starch, without harmful effects on health and simulating Dexamethasone (Celsius Laboratory, Montevideo, Uruguay).).
Device:
Simulation Photobiomodulation
The irradiation simulations will be practiced in the same anatomical points described in the experimental group. This protocol will be carried out 1 hour before the surgical procedure (Baseline). The Laser device will be disconnected and its beep sound will be recorded and run on simulating the irradiation.
Drug:
Corticosteroid
The patients will receive Dexamethasone 8 mg (Corodex, Laboratorio Celsius, Montevideo, Uruguay) PO 1 hour before surgery (Almeida et al 2019)

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University of Nove de Julho

Outcome

Type Measure Description Time frame Safety issue
Primary Postoperative Edema baseline To evaluate post-surgical edema (Ustun et al, 2003, Mello et al, 2001), 3 measurements will be determined on the patient's face, with a malleable tape measure graduated in mm (millimeters), previously sanitized, as follows: tragus-pogonion; tragus- labial commissure and mandibular angle (gonion)- external corner of the eye (external canthus). The reference points will be marked with indelible dermographic ink and will remain unchanged throughout the post-surgical evaluation period, for this purpose The patient will be asked to ensure the unaltered conservation of those points Edema wil be evaluated immediatly before the surgery (baseline)
Primary Postoperative Edema - 48 hours postoperative To evaluate post-surgical edema (Ustun et al, 2003, Mello et al, 2001), 3 measurements will be determined on the patient's face, with a malleable tape measure graduated in mm (millimeters), previously sanitized, as follows: tragus-pogonion; tragus- labial commissure and mandibular angle (gonion)- external corner of the eye (external canthus). The reference points will be marked with indelible dermographic ink and will remain unchanged throughout the post-surgical evaluation period, for this purpose The patient will be asked to ensure the unaltered conservation of those points. Edema wil be evaluated at 2 postoperative days.
Primary Postoperative Edema - 7day postoperative To evaluate post-surgical edema (Ustun et al, 2003, Mello et al, 2001), 3 measurements will be determined on the patient's face, with a malleable tape measure graduated in mm (millimeters), previously sanitized, as follows: tragus-pogonion; tragus- labial commissure and mandibular angle (gonion)- external corner of the eye (external canthus). The reference points will be marked with indelible dermographic ink and will remain unchanged throughout the post-surgical evaluation period, for this purpose The patient will be asked to ensure the unaltered conservation of those points. Edema wil be evaluated at 7 postoperative days.
Secondary Postoperative Pain baseline Pain sensitivity - The Visual Analogue Scale (VAS) is the most commonly used instrument for the assessment of postoperative pain in oral surgeries when FBM is used as post-surgical palliative therapy (Yüksek, Eroglu 2021, Momeni et al 2021, Amarillas -Escobar et al 2010, López-Ramírez et al 2011, Brignardello-Petersen et al 2012, Sierra et al 2013, Sierra et al 2015).
A rule will be used, graduated in cm, 10 cm long. One of the extremes represents "0", which means "no pain" and the other represents "10" which indicates "unbearable pain". The intermediate graduation gives patients the possibility of rating the intensity of their painful experience, from 0 to 10. This rule will be the same for all study participants and the indications for its use and marking will be given to the patient, always by the same operator
In this study, the VAS will be used immediately before surgery (Baseline)
Secondary Postoperative Pain - 48 hours Pain sensitivity - The Visual Analogue Scale (VAS) is the most commonly used instrument for the assessment of postoperative pain in oral surgeries when FBM is used as post-surgical palliative therapy (Yüksek, Eroglu 2021, Momeni et al 2021, Amarillas -Escobar et al 2010, López-Ramírez et al 2011, Brignardello-Petersen et al 2012, Sierra et al 2013, Sierra et al 2015).
A rule will be used, graduated in cm, 10 cm long. One of the extremes represents "0", which means "no pain" and the other represents "10" which indicates "unbearable pain". The intermediate graduation gives patients the possibility of rating the intensity of their painful experience, from 0 to 10. This rule will be the same for all study participants and the indications for its use and marking will be given to the patient, always by the same operator
In this study, the VAS will be used at 2 postoperative days
Secondary Postoperative Pain - 7 days Pain sensitivity - The Visual Analogue Scale (VAS) is the most commonly used instrument for the assessment of postoperative pain in oral surgeries when FBM is used as post-surgical palliative therapy (Yüksek, Eroglu 2021, Momeni et al 2021, Amarillas -Escobar et al 2010, López-Ramírez et al 2011, Brignardello-Petersen et al 2012, Sierra et al 2013, Sierra et al 2015).
A rule will be used, graduated in cm, 10 cm long. One of the extremes represents "0", which means "no pain" and the other represents "10" which indicates "unbearable pain". The intermediate graduation gives patients the possibility of rating the intensity of their painful experience, from 0 to 10. This rule will be the same for all study participants and the indications for its use and marking will be given to the patient, always by the same operator
In this study, the VAS will be used 7 days before surgery
Secondary Postoperative use of analgesics - baseline Amount of analgesics necessarily ingested, as a rescue: The amount of analgesic (Acetaminophen), a drug with a purely analgesic effect (Józwiak-Bebenista 2014) ingested by the patient (500 mg every 6 hours if the pain continues), will be recorded. At the beginning of the investigation, each patient will be given a form to record daily consumption, after the 3rd. post-operative day, and must be kept until the end of its use, at surgical discharge. At the end of the study, the amount of Acetaminophen tablets used will be evaluated as a secondary variable. The adherence of the participants to the study will be monitored through this means, asking the patients to present the form to verify its use. The amount of analgesics will be recorded in the baseline.
Secondary Postoperative use of analgesics - 7th days Amount of analgesics necessarily ingested, as a rescue: The amount of analgesic (Acetaminophen), a drug with a purely analgesic effect (Józwiak-Bebenista 2014) ingested by the patient (500 mg every 6 hours if the pain continues), will be recorded. At the beginning of the investigation, each patient will be given a form to record daily consumption, after the 3rd. post-operative day, and must be kept until the end of its use, at surgical discharge. At the end of the study, the amount of Acetaminophen tablets used will be evaluated as a secondary variable. The adherence of the participants to the study will be monitored through this means, asking the patients to present the form to verify its use. The amount of analgesics will be recorded after the third postoperative day until the 7th. post-operative day.
Secondary Postoperative Trismus - baseline Evaluation of post-operative trismus- Spasms in the masticatory muscles (lockjaw) can limit or even prevent the normal opening of the mouth after surgical removal of impacted lower third molars (Yüksek, Eroglu, 2021, López-Ramírez et al ., 2012; Aras; Güngörmüs, 2009; Aras; Güngörmüs, 2010; Amarillas-Escobar et al., 2010; Ferrante et al., 2013). This result is generally evaluated by measuring the distance between the incisal edges of the upper and lower central incisors, using a caliper, graduated in mm (millimeters) (Yüksek, Eroglu, 2021, Sampaio-Filho et al., 2017 , Bauer et al. 2013). In the present study, the previously calibrated evaluators will measure the mouth opening in each patient before the surgeries (baseline)
Secondary Postoperative Trismus 48 hours Evaluation of post-operative trismus- Spasms in the masticatory muscles (lockjaw) can limit or even prevent the normal opening of the mouth after surgical removal of impacted lower third molars (Yüksek, Eroglu, 2021, López-Ramírez et al ., 2012; Aras; Güngörmüs, 2009; Aras; Güngörmüs, 2010; Amarillas-Escobar et al., 2010; Ferrante et al., 2013). This result is generally evaluated by measuring the distance between the incisal edges of the upper and lower central incisors, using a caliper, graduated in mm (millimeters) (Yüksek, Eroglu, 2021, Sampaio-Filho et al., 2017 , Bauer et al. 2013). In the present study, the previously calibrated evaluators will measure the mouth opening in each patient at 2 postoperative days.
Secondary Postoperative Trismus - 7 days Evaluation of post-operative trismus- Spasms in the masticatory muscles (lockjaw) can limit or even prevent the normal opening of the mouth after surgical removal of impacted lower third molars (Yüksek, Eroglu, 2021, López-Ramírez et al ., 2012; Aras; Güngörmüs, 2009; Aras; Güngörmüs, 2010; Amarillas-Escobar et al., 2010; Ferrante et al., 2013). This result is generally evaluated by measuring the distance between the incisal edges of the upper and lower central incisors, using a caliper, graduated in mm (millimeters) (Yüksek, Eroglu, 2021, Sampaio-Filho et al., 2017 , Bauer et al. 2013). In the present study, the previously calibrated evaluators will measure the mouth opening in each patient after 7 postoperative days.
Secondary Postoperative Local temperature baseline Local temperature -To evaluate it a thermographic photograph of the facial skin in the operated area will be taken using a FLIR C5sc 9 camera (Teledyne FLIR, Wilsonville, Oregon, USA). . The quantification of the temperature will be carried out by means of the FLIR Research IR thermal analysis software. In all photographic records, the camera-patient distance will be kept constant, as will the ambient temperature of the place where the thermographic records are made. baseline
Secondary Postoperative Local temperature 48 hours Local temperature -To evaluate it a thermographic photograph of the facial skin in the operated area will be taken using a FLIR C5sc 9 camera (Teledyne FLIR, Wilsonville, Oregon, USA). . The quantification of the temperature will be carried out by means of the FLIR Research IR thermal analysis software. In all photographic records, the camera-patient distance will be kept constant, as will the ambient temperature of the place where the thermographic records are made. Thermographic photographs wil be taken 2 days after surgery.
Secondary Postoperative Local temperature - 7 days Local temperature -To evaluate it a thermographic photograph of the facial skin in the operated area will be taken using a FLIR C5sc 9 camera (Teledyne FLIR, Wilsonville, Oregon, USA). . The quantification of the temperature will be carried out by means of the FLIR Research IR thermal analysis software. In all photographic records, the camera-patient distance will be kept constant, as will the ambient temperature of the place where the thermographic records are made. Thermographic photographs wil be taken 7 days after surgery.
Secondary Postoperative Quality of life - baseline Impact of the surgical procedure on the quality of life of patients - Two previously calibrated evaluators will ask patients to answer YES or NO to the following 10 questions, as described by Colorado- Bonin et al., 2006; Sato et al., 2009; savin; Grossi et al., 2007, Sierra et al. 2013, Sierra et al. 2015.
Are you maintaining your social activities normally?
Are you working and/or studying normally?
Are you maintaining a normal diet?
Do you have difficulty swallowing because of the surgery?
Do you have difficulty perceiving the taste of food?
Can you chew on the operated side?
Do you have difficulty sleeping because of the surgery?
Do you have difficulty speaking because of the surgery?
Has your physical appearance changed because of the surgery?
Are you angry about the surgery?
Quality of life will be evaluated in the baseline
Secondary Postoperative Quality of life - 48 hours Impact of the surgical procedure on the quality of life of patients - Two previously calibrated evaluators will ask patients to answer YES or NO to the following 10 questions, as described by Colorado- Bonin et al., 2006; Sato et al., 2009; savin; Grossi et al., 2007, Sierra et al. 2013, Sierra et al. 2015.
Are you maintaining your social activities normally?
Are you working and/or studying normally?
Are you maintaining a normal diet?
Do you have difficulty swallowing because of the surgery?
Do you have difficulty perceiving the taste of food?
Can you chew on the operated side?
Do you have difficulty sleeping because of the surgery?
Do you have difficulty speaking because of the surgery?
Has your physical appearance changed because of the surgery?
Are you angry about the surgery?
Quality of life will be evaluated two days after surgery,
Secondary Postoperative Quality of life - 7 days Impact of the surgical procedure on the quality of life of patients - Two previously calibrated evaluators will ask patients to answer YES or NO to the following 10 questions, as described by Colorado- Bonin et al., 2006; Sato et al., 2009; savin; Grossi et al., 2007, Sierra et al. 2013, Sierra et al. 2015.
Are you maintaining your social activities normally?
Are you working and/or studying normally?
Are you maintaining a normal diet?
Do you have difficulty swallowing because of the surgery?
Do you have difficulty perceiving the taste of food?
Can you chew on the operated side?
Do you have difficulty sleeping because of the surgery?
Do you have difficulty speaking because of the surgery?
Has your physical appearance changed because of the surgery?
Are you angry about the surgery?
Quality of life will be evaluated seven days after surgery,
Secondary Postoperative Dysphagia baseline Dysphagia - The evaluation of dysphagia will be carried out through a questionnaire (Sampaio-Filho et al., 2017) that will classify on a numerical scale as follows:
(0)= total absence of dysphagia.
= dysphagia to solid foods.
= dysphagia to any food, liquid or solid.
Dysphagia will be evaluated at baseline
Secondary Postoperative Dysphagia 48 hours Dysphagia - The evaluation of dysphagia will be carried out through a questionnaire (Sampaio-Filho et al., 2017) that will classify on a numerical scale as follows:
(0)= total absence of dysphagia.
= dysphagia to solid foods.
= dysphagia to any food, liquid or solid.
Dysphagia will be evaluated at 2 days post-surgery
Secondary Postoperative Dysphagia - 7 days Dysphagia - The evaluation of dysphagia will be carried out through a questionnaire (Sampaio-Filho et al., 2017) that will classify on a numerical scale as follows:
(0)= total absence of dysphagia.
= dysphagia to solid foods.
= dysphagia to any food, liquid or solid.
Dysphagia will be evaluated 7 days post-surgery
Secondary Postoperative Hematoma/ecchymosis - baseline The presence of hematoma/ecchymosis will be evaluated by measuring the largest diameter of the colorimetric changes in the skin of the jugal and submandibular region with a millimetric graduated malleable rule. The measurement will be carried out by the previously calibrated evaluator, who will classify the appearance of this finding into 4 categories:
non-existent;
the largest diameter is less than 4 cm;
the largest diameter is between 4 and 10 cm;
the largest diameter is greater than 10 cm; as described by Bjornsson et al., (2003).
Hematoma/ecchymosis will be evaluated at baseline
Secondary Postoperative Hematoma/ecchymosis The presence of hematoma/ecchymosis will be evaluated by measuring the largest diameter of the colorimetric changes in the skin of the jugal and submandibular region with a millimetric graduated malleable rule. The measurement will be carried out by the previously calibrated evaluator, who will classify the appearance of this finding into 4 categories:
non-existent;
the largest diameter is less than 4 cm;
the largest diameter is between 4 and 10 cm;
the largest diameter is greater than 10 cm; as described by Bjornsson et al., (2003).
Hematoma/ecchymosis will be evaluated 2 days after surgery,
Secondary Postoperative Hematoma/ecchymosis - 7 days The presence of hematoma/ecchymosis will be evaluated by measuring the largest diameter of the colorimetric changes in the skin of the jugal and submandibular region with a millimetric graduated malleable rule. The measurement will be carried out by the previously calibrated evaluator, who will classify the appearance of this finding into 4 categories:
non-existent;
the largest diameter is less than 4 cm;
the largest diameter is between 4 and 10 cm;
the largest diameter is greater than 10 cm; as described by Bjornsson et al., (2003).
Hematoma/ecchymosis will be evaluated 7 days after surgery,
See also
  Status Clinical Trial Phase
Recruiting NCT05722509 - Evaluation of a New Technique for Periodontal Pocket Reduction in the Extraction of Wisdom Teeth N/A
Completed NCT05992233 - "Effectiveness of Dual-Wavelength Laser Therapy in Third Molar Extraction Pain, Swelling, and Trismus" N/A
Withdrawn NCT05374993 - An Early Feasibility Evaluation of a Novel 3rdMolarTooth Bud Ablation Procedure N/A
Recruiting NCT05923775 - Pain and Trismus Control in Third Molar Surgery: Ibuprofen, Ketamine, and Their Combination N/A
Completed NCT04182191 - Influence of CYP2C9 Genotype on Clinical Efficacy of Tenoxicam Phase 4
Completed NCT04203771 - Probiotic Intervention After Surgical Removal of Mandibular Third Molars N/A
Not yet recruiting NCT06452134 - Evaluation the Effect of Coenzyme Q10 on Tissue Healing Process in Patients Undergoing Wisdom Tooth Extraction Phase 4
Recruiting NCT05941130 - 3D Evaluation of Postoperative Edema After Third Molar Surgery Phase 4
Completed NCT04033744 - Prevention of Mandibular Third Molar Extraction- Associated Periodontal Defects Using Platelet-Rich Fibrin N/A
Completed NCT00154518 - The Role of Matrix Metalloproteinases (MMPs) in Orthodontic Tooth Movement Phase 1
Active, not recruiting NCT06073535 - The Use of Injectable-Platelet Rich Fibrin (i-PRF) in the Lower Third Molar Extraction N/A
Completed NCT03545022 - Acupuncture on Anxiety and Inflammatory Events Following Surgery of Mandibular Third Molars N/A
Completed NCT02890680 - Effects of the Use of Platelet-rich Fibrin on Bone Regeneration After Impacted Third Molar Surgery N/A
Recruiting NCT02284841 - Effect of Hilotherm Therapy on Post-operative Pain and Swelling Following Surgical Wisdom Tooth Removal N/A
Recruiting NCT01896427 - Comparing Pain and Swelling After Surgical Extraction of Mandibular Third Molar in Dexamethasone Injection and Without Corticosteroid Methods Phase 4
Enrolling by invitation NCT03567369 - 92/5000 Preoperative Efficacy of Traumeel Versus Dexamethasone in the Control of Pain, Swelling and Trismus N/A